{"id":68897,"date":"2026-03-02T18:06:52","date_gmt":"2026-03-02T18:06:52","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68897"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"ipamorelin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/ipamorelin\/","title":{"rendered":"Ipamorelina"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es el Ipamorelin?<\/h3>\n<p style=\"margin: 0;\"><strong>Ipamorelina<\/strong> es un pentap\u00e9ptido sint\u00e9tico secretagogo de la hormona del crecimiento que se une al receptor de grelina (GHS-R1a) para desencadenar la liberaci\u00f3n puls\u00e1til de GH <strong>sin<\/strong> raising cortisol or prolactin \u2014 a selectivity that distinguishes it from older GHRPs. in studies it is frequently stacked with CJC-1295 to amplify GH pulse amplitude. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">170851-70-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>38<\/sub>H<sub>49<\/sub>N<sub>9<\/sub>O<sub>5<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">711.86 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Aib-His-D-2-Nal-D-Phe-Lys-NH<sub>2<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (o seg\u00fan suministro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar dentro de ~30 d\u00edas. Proteger de la luz. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua bacteriost\u00e1tica (recomendada) o agua est\u00e9ril para periodos de uso m\u00e1s cortos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es el Ipamorelin?<\/h2>\n<p><strong>Ipamorelina<\/strong> es un pentap\u00e9ptido sint\u00e9tico perteneciente a la familia de los p\u00e9ptidos liberadores de hormona del crecimiento (GHRP). Desarrollado por Novo Nordisk en la d\u00e9cada de 1990 y caracterizado por primera vez por Raun et al. (Eur J Endocrinol, 1998), se clasifica como un <strong>secretagogo de la hormona del crecimiento<\/strong> \u2014 a compound that triggers endogenous GH release by activating the ghrelin receptor (GHS-R1a) on pituitary somatotropes. Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH<sub>2<\/sub>. Peso molecular aproximadamente 711.9 Da. A diferencia de los GHRP anteriores (GHRP-2, GHRP-6, hexarelina), el ipamorelin destaca por su <strong>selectividad hormonal limpia<\/strong> \u2014 it releases GH without meaningfully raising cortisol, prolactin, or ACTH. This selectivity is why ipamorelin has become the most-studied GHRP of the 21st century. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, published studies, and stacking protocols, see our <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin &amp; CJC-1295 guide<\/a>. <\/p>\n<h2>Mecanismo de acci\u00f3n \u2014 Agonismo selectivo del receptor de grelina<\/h2>\n<p>El ipamorelin se une al <strong>receptor secretagogo de la hormona del crecimiento tipo 1a (GHS-R1a)<\/strong>, el receptor end\u00f3geno de la grelina. El receptor se expresa en los somatotropos pituitarios y en el n\u00facleo arqueado hipotal\u00e1mico, y su activaci\u00f3n desencadena una liberaci\u00f3n puls\u00e1til de hormona del crecimiento a partir de los gr\u00e1nulos de almacenamiento pituitarios. <\/p>\n<ul>\n<li><strong>Liberaci\u00f3n puls\u00e1til de GH<\/strong> \u2014 a diferencia de la administraci\u00f3n continua de GH recombinante, el ipamorelin produce un perfil de GH <em>puls\u00e1til<\/em> que imita m\u00e1s de cerca las r\u00e1fagas nocturnas end\u00f3genas de GH. Esta pulsatilidad es importante desde el punto de vista mec\u00e1nico porque la se\u00f1alizaci\u00f3n de IGF-1 responde mejor a la exposici\u00f3n puls\u00e1til que a la continua de GH.<\/li>\n<li><strong>Selectividad hormonal limpia<\/strong> \u2014 the defining feature of ipamorelin. Older GHRPs (GHRP-2, GHRP-6, hexarelin) also raise cortisol and prolactin, producing off-target effects that complicate studies interpretation. Ipamorelin does not, making it the preferred GHRP for studies where those confounders matter.<\/li>\n<li><strong>Complementariedad con GHRH<\/strong> \u2014 el ipamorelin act\u00faa a trav\u00e9s de la v\u00eda del receptor de grelina; los an\u00e1logos de GHRH como <a href=\"https:\/\/medsbase.com\/es\/cjc-1295-with-dac\/\">CJC-1295<\/a> act via a parallel GHRH-receptor pathway. Co-administration produces synergistic GH pulse amplification greater than either peptide alone \u2014 the basis of the classic &#8220;ipamorelin + CJC-1295&#8221; stack.<\/li>\n<\/ul>\n<p>Because ipamorelin works through the body&#8217;s own pituitary GH supply, it is subject to normal negative-feedback regulation by somatostatin and IGF-1. This auto-regulation is a studies-relevant safety feature distinguishing secretagogues from exogenous recombinant GH. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Ipamorelin is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>GH pulse studies<\/strong> \u2014 cin\u00e9tica de liberaci\u00f3n puls\u00e1til de hormona de crecimiento y respuesta de IGF-1 en modelos de roedores (Raun et al., Eur J Endocrinol 1998)<\/li>\n<li><strong>Recuperaci\u00f3n del m\u00fasculo esquel\u00e9tico<\/strong> \u2014 recuperaci\u00f3n post-lesi\u00f3n y post-ejercicio, a menudo combinado con <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> y <a href=\"https:\/\/medsbase.com\/es\/tb-500\/\">TB-500<\/a><\/li>\n<li><strong>Body composition studies<\/strong> \u2014 lean-mass preservation and fat-mass studies, often in caloric-deficit or disuse-atrophy models<\/li>\n<li><strong>Sleep studies<\/strong> \u2014 slow-wave sleep and nocturnal GH-surge studies; pre-sleep dosing is the typical studies timing<\/li>\n<li><strong>Bone density studies<\/strong> \u2014 actividad osteobl\u00e1stica y densidad mineral \u00f3sea mediante la modulaci\u00f3n del eje GH\/IGF-1<\/li>\n<li><strong>CJC-1295 stacking studies<\/strong> \u2014 protocolos de amplificaci\u00f3n sin\u00e9rgica de GH con an\u00e1logos de GHRH (ver la <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">Gu\u00eda de combinaci\u00f3n Ipamorelin + CJC-1295<\/a>)<\/li>\n<\/ul>\n<p>Para un contexto m\u00e1s amplio sobre el panorama de los p\u00e9ptidos del eje GH, consulta <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">the peptides catalog<\/a>. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase ofrece ipamorelin en los siguientes tama\u00f1os de viales liofilizados. Cada variaci\u00f3n se env\u00eda en paquetes de 10, 20 o 30 viales:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, most commonly ordered<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended studies, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). A 5\u00a0mg vial at 2.5\u00a0mg\/mL dilution delivers approximately 16 administrations of 300\u00a0mcg, matching common protocols. <\/p>\n<h2>Comparativa \u2014 Ipamorelin frente a CJC-1295<\/h2>\n<p>Ipamorelin y <a href=\"https:\/\/medsbase.com\/es\/cjc-1295-with-dac\/\">CJC-1295 con DAC<\/a> son los dos p\u00e9ptidos del eje GH m\u00e1s estudiados. Casi siempre se coadministran en lugar de sustituirse, ya que act\u00faan en <em>sistemas de receptores<\/em> paralelos que producen sinergia juntos:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelina<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 con DAC<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Clase de p\u00e9ptido<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRP (p\u00e9ptido liberador de hormona del crecimiento)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">An\u00e1logo de GHRH (hormona liberadora de hormona del crecimiento)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Receptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHS-R1a (receptor de grelina)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Receptor de GHRH en somatotropas<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Efecto sobre la GH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Liberaci\u00f3n puls\u00e1til en r\u00e1fagas<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Elevaci\u00f3n sostenida de la l\u00ednea base<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Vida media<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 horas<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~7 d\u00edas (unido a alb\u00famina)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Posolog\u00eda<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013300\u00a0mcg, 2\u20133 veces al d\u00eda<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132\u00a0mg semanal<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Combinaci\u00f3n<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Emparejamiento can\u00f3nico con CJC-1295<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Emparejamiento can\u00f3nico con ipamorelina<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>El an\u00e1lisis completo de la l\u00f3gica de combinaci\u00f3n, el momento de la dosis y el mecanismo de sinergia se encuentra en nuestra <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin and CJC-1295 stack guide<\/a>. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original, estables hasta 36 meses. Evite los ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inyectar agua bacteriost\u00e1tica por la pared lateral del vial de p\u00e9ptidos seg\u00fan el cuadro anterior. Agitar suavemente \u2014 no <strong>ajuste<\/strong> agite y permita 5\u201310 minutos para una disoluci\u00f3n completa. Una soluci\u00f3n correctamente reconstituida debe ser clara e incolora. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> almacene refrigerado a 2\u20138\u00a0\u00b0C y use dentro de los 30 d\u00edas. No congele la soluci\u00f3n reconstituida \u2014 los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan la integridad del p\u00e9ptido. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is ipamorelin used for in studies?<\/h3>\n<p>Ipamorelin is used in studies investigating pulsatile growth hormone release, IGF-1 axis signaling, skeletal muscle recovery, body composition, sleep studies, bone density, and GH-axis stacking with GHRH analogs. It is <strong>ajuste<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>What is the typical ipamorelin dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013300\u00a0mcg per administration, 2\u20133 times daily, often with one dose timed pre-sleep to align with nocturnal GH-surge studies. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 12 ticks on a U-100 syringe delivers 300\u00a0mcg. <\/p>\n<h3>\u00bfEn qu\u00e9 se diferencia el ipamorelin del CJC-1295?<\/h3>\n<p>El ipamorelin es un GHRP (p\u00e9ptido liberador de hormona del crecimiento) que se une al receptor de grelina para liberar GH de forma puls\u00e1til. El CJC-1295 es un an\u00e1logo de GHRH (hormona liberadora de hormona del crecimiento) que se une a un receptor diferente en las mismas c\u00e9lulas pituitarias para una elevaci\u00f3n sostenida de GH. Ambos suelen combinarse porque sus mecanismos son aditivos\/sin\u00e9rgicos. <\/p>\n<h3>\u00bfEst\u00e1 aprobado el ipamorelin por la FDA?<\/h3>\n<p>No. Ipamorelin is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. It has been studied in early-phase human clinical trials but never advanced to approval. All ipamorelin sold by specialist suppliers is for clinical investigation only. <\/p>\n<h3>\u00bfPor qu\u00e9 se prefiere el ipamorelin frente a GHRPs m\u00e1s antiguos como el GHRP-6?<\/h3>\n<p>Ipamorelin&#8217;s defining feature is clean hormonal selectivity \u2014 it releases GH without raising cortisol, prolactin, or ACTH. Older GHRPs (GHRP-2, GHRP-6, hexarelin) raise all three, producing off-target effects that complicate studies interpretation and produce unwanted side effects. This selectivity has made ipamorelin the most-studied GHRP of the past two decades. <\/p>\n<h3>\u00bfC\u00f3mo se debe almacenar el ipamorelin?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138 \u00b0C en su envase original, estables hasta 36 meses. Soluci\u00f3n reconstituida: refrigerada a 2\u20138 \u00b0C, usar en 30 d\u00edas. No congelar la soluci\u00f3n reconstituida \u2014 los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan el p\u00e9ptido. <\/p>\n<h3>\u00bfC\u00f3mo se reconstituye el ipamorelin?<\/h3>\n<p>Sigue la tabla de reconstituci\u00f3n anterior. A\u00f1ade agua bacteriost\u00e1tica por la pared lateral del vial, agita suavemente y deja reposar entre 5 y 10 minutos para una disoluci\u00f3n completa. No <strong>ajuste<\/strong> Agitar el vial. <\/p>\n<h3>Can ipamorelin and CJC-1295 be stacked in studies?<\/h3>\n<p>Yes. The ipamorelin + CJC-1295 combination is the canonical GH-axis stack. The two peptides act on parallel receptor systems (ghrelin vs GHRH receptor) and their effects on GH release are synergistic \u2014 combined use produces larger GH pulses than either alone. See our <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">gu\u00eda de combinaciones<\/a>. <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase ofrece ipamorelin en viales liofilizados de 2 mg, 5 mg y 10 mg. Cada concentraci\u00f3n est\u00e1 disponible en tama\u00f1os de paquete de 10, 20 o 30 viales. Todos los viales tienen una pureza HPLC de 99%+ con certificado de an\u00e1lisis bajo petici\u00f3n. <\/p>\n<h3>Does ipamorelin cause side reported effects?<\/h3>\n<p>Ipamorelin has been reported with a clean safety profile at typical doses. Its selective receptor binding avoids the cortisol and prolactin elevation seen with older GHRPs. Long-term human safety data are not available because human trials were not completed. <\/p>\n<h3>Why is pre-sleep timing used in ipamorelin studies?<\/h3>\n<p>Endogenous growth-hormone release is naturally pulsatile and strongest during slow-wave sleep. Study protocols typically time one ipamorelin dose 30\u201360 minutes before sleep to amplify the natural nocturnal GH surge rather than compete with daytime somatostatin tone. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media del ipamorelin?<\/h3>\n<p>Ipamorelin has a short plasma half-life of approximately 2 hours in preclinical studies, consistent with the broader GHRP peptide class. This rapid clearance underpins the pulsatile, multiple-daily dosing schedules most commonly used in ipamorelin protocols. <\/p>\n<h3>How does Ipamorelin compare to GHRP-6 in studies?<\/h3>\n<p>Ipamorelin is highly selective for the GHSR-1a receptor and does not significantly elevate cortisol or prolactin in preclinical studies \u2014 a key distinction from GHRP-6, which activates ghrelin receptors more broadly and is associated with transient cortisol and prolactin increases. This selectivity is a primary reason ipamorelin is frequently preferred in published GH-secretagogue studies. <\/p>\n<h3>\u00bfPuedo pedir ipamorelin para env\u00edo internacional?<\/h3>\n<p>S\u00ed. MedsBase env\u00eda ipamorelin a todo el mundo desde nuestra red dedicada de env\u00edo de p\u00e9ptidos. Los pedidos que solo contienen p\u00e9ptidos califican para nuestro servicio de env\u00edo de p\u00e9ptidos independiente. Los pedidos se env\u00edan en embalaje con control de temperatura y seguimiento completo. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Si tu protocolo de recuperaci\u00f3n combina la estimulaci\u00f3n de pulsos de GH del ipamorelin con p\u00e9ptidos de reparaci\u00f3n tisular directa para trabajo en tendones o ligamentos, nuestro <a href=\"\/es\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg)<\/a> cubre el lado de angiog\u00e9nesis + reparaci\u00f3n del citoesqueleto del r\u00e9gimen, incluyendo agua bacteriost\u00e1tica para su reconstituci\u00f3n.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/es\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/es\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH con vida media extendida<\/li>\n<li><a href=\"\/es\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/es\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lee nuestra gu\u00eda completa basada en evidencia: <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\"><strong>Ipamorelin &amp; CJC-1295 \u2014 mecanismo, combinaci\u00f3n y protocolos<\/strong><\/a>. Cubre el mecanismo de acci\u00f3n, farmacolog\u00eda de receptores de grelina vs GHRH, protocolos de combinaci\u00f3n publicados, reconstituci\u00f3n, horario de dosis y notas de seguridad.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorece el desarrollo de masa muscular magra<br \/>\n\u2705 Mejora las v\u00edas de recuperaci\u00f3n<br \/>\n\u2705 Promueve el equilibrio metab\u00f3lico<br \/>\n\u2705 Mejora los ciclos de sue\u00f1o<br \/>\n\u2705 Estimula la reparaci\u00f3n de tejidos<\/p>\n<p><strong>Ipamorelina<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70961,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5457],"class_list":["post-68897","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-ipamorelin","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/68897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=68897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70961"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=68897"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=68897"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=68897"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=68897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}